Innogenetics, Third Wave Resolve Patent Suit
News Feb 13, 2006
Third Wave Technologies Inc. and Innogenetics have jointly announced that the companies have reached an agreement by which Third Wave Technologies will receive a non-exclusive license to sell hepatitis C virus (HCV) genotyping products in the United States.
The agreement also includes certain opt-out rights for Third Wave, as well as an option to extend both the term and global reach of the license to Innogenetics’ HCV genotyping patent estate.
The conclusion of the agreement resolves the patent litigation between Innogenetics and Third Wave.
Kevin Conroy, president and chief executive of Third Wave, said, "We are pleased to have resolved the litigation and to have concluded a licensing agreement with Innogenetics for the rights to its HCV genotyping patent estate."
"This deal will help to accelerate the global growth of our molecular diagnostics business and further build shareholder value."
Frank Morich, CEO of Innogenetics, also commented on the deal, "We are particularly happy to have concluded this licensing agreement. The amicable resolution of this issue will help both companies realize their ambitious near- and mid-term goals."
"With leading diagnostics companies such as Bayer HealthCare (Diagnostics Division), Roche Diagnostics, and Third Wave Technologies now having taken licenses to Innogenetics’ HCV genotyping technologies and patent estate, we remain determined to further enrich and enforce our HCV genotyping patent portfolio worldwide."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018